secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-07-16T23:59:59+00:00
Accession:  0001641172-25-019893
Event type: regulatory
Sentiment:  positive
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics regains Nasdaq minimum bid price compliance
-----------------------------------------------------------------

- Received Nasdaq notice on July 14, 2025 that closing bid price was ≥$1.00 for 10 consecutive business days (June 27-July 11, 2025).
- Previously reported non-compliance on January 31, 2025; had until July 30, 2025 to regain compliance.
- Nasdaq considers the bid price deficiency matter now closed.
- Regaining compliance removes imminent delisting risk from The Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225019893/0001641172-25-019893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225019893/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-019893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer